Functional Hypothalamic Amenorrhea (FHA) is the Most Likely Diagnosis
Based on the hormone pattern—low-normal FSH (2.93 IU/L) and LH (3.3 IU/L), estradiol 73 pg/mL (which is low but above the critical <50 pg/mL threshold), normal prolactin (16 ng/mL), and low testosterone (25 ng/dL)—this presentation is most consistent with functional hypothalamic amenorrhea. 1
Diagnostic Interpretation
The hormone pattern here requires careful analysis of relative values rather than absolute numbers:
FSH and LH are low-normal: In FHA, gonadotropins are characteristically low or low-normal, with FSH typically higher than LH. Your patient shows FSH 2.93 and LH 3.3, which fits this pattern (though the FSH/LH ratio is slightly inverted, this can occur in FHA) 1
Estradiol at 73 pg/mL: This is the key distinguishing feature. In classic FHA, estradiol is typically <50 pg/mL. However, estradiol measurements reflect a single time point and can fluctuate. The value of 73 pg/mL suggests some residual ovarian function but still indicates hypogonadism 1
Normal prolactin (16 ng/mL): This effectively rules out hyperprolactinemia as a cause. In FHA, prolactin is characteristically in the low-normal range 1
Low testosterone (25 ng/dL): This is consistent with overall hypogonadism and rules out PCOS or hyperandrogenic conditions 1
What This Pattern Rules Out
- Primary ovarian insufficiency: Would show elevated FSH and LH (typically >20-40 IU/L) with low estradiol (<20 pg/mL) 1
- Hyperprolactinemia: Prolactin is normal 1
- PCOS: Would show elevated LH/FSH ratio (typically >2-3) with normal or elevated testosterone and estradiol 1
- Organic hypothalamic amenorrhea: Would show very low or undetectable LH and FSH, suggesting pituitary/hypothalamic tumors or infiltrative lesions 1
Critical Next Steps
1. Complete the Initial Endocrine Workup
You still need 1:
- TSH and free T4: To rule out thyroid dysfunction (both hypo- and hyperthyroidism can cause amenorrhea)
- AMH (anti-Müllerian hormone): To assess ovarian reserve
- Consider 8 AM cortisol: FHA patients often have altered HPA axis function
2. Rule Out Pregnancy
- β-hCG: Must be obtained first in any reproductive-age woman with amenorrhea 1
3. Assess for Underlying Causes of FHA
Focus your history and examination on:
- Energy availability: Caloric intake vs. expenditure (eating disorders, restrictive dieting, excessive exercise)
- Weight history: Recent weight loss, current BMI, lowest adult weight
- Exercise patterns: Hours per week, type of exercise (endurance athletes at high risk)
- Psychological stress: Major life stressors, anxiety, depression
- Chronic illness: Screen with CBC, comprehensive metabolic panel, liver function tests, ESR/CRP 1
4. Consider GnRH Stimulation Test Only If Needed
If estradiol remains persistently <20 pg/mL on repeat testing, a GnRH stimulation test can differentiate FHA (preserved 2-3 fold LH/FSH response) from organic hypogonadotropic hypogonadism (blunted response) 1. However, with estradiol at 73 pg/mL, this is likely unnecessary.
Common Pitfalls to Avoid
Don't be misled by "normal" FSH/LH values: In the context of low estradiol, these should be elevated (negative feedback). "Normal" gonadotropins with low estradiol indicate hypothalamic-pituitary dysfunction 1
Single estradiol measurement limitations: Estradiol fluctuates throughout the cycle. If clinical suspicion for FHA is high despite estradiol of 73 pg/mL, repeat testing may show lower values 1
Don't assume PCOS based on LH/FSH ratio alone: While the LH is slightly higher than FSH here, the overall low gonadotropins and low testosterone argue against PCOS 1
Treatment Implications for Morbidity and Mortality
Once FHA is confirmed, addressing the underlying cause is critical for:
- Bone health: Hypoestrogenism leads to accelerated bone loss and increased fracture risk
- Cardiovascular health: Estrogen deficiency increases cardiovascular risk
- Fertility: Restoration of normal menstrual function
- Quality of life: Addressing psychological stressors, body image issues, and energy balance
The primary treatment is addressing the underlying energy deficit, reducing excessive exercise, and managing psychological stress—not simply prescribing hormone replacement 1.